Related Experiment Video
Updated: Aug 9, 2025

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
Published on: October 10, 2022
Diverse roles of UBE2T in cancer (Review)
Nengqian Ma1, Zhangzhan Li2, Jingting Yan3
1Department of Hepatobiliary Surgery, Affiliated Nanhua Hospital, Hengyang Medical College, University of South China, Zhuhui, Hengyang, Hunan 421002, P.R. China.
Abstract:
As a leading cause of mortalities worldwide, cancer results from accumulation of both genetic and epigenetic alterations. Disruption of epigenetic regulation in cancer, particularly aberrant ubiquitination, has drawn increasing interest in recent years. The present study aimed to review the roles of ubiquitin‑conjugating enzyme E2 T (UBE2T) and its associated pathways in the pathogenesis of pan‑cancer, and the development of small‑molecule modulators to regulate ubiquitination for treatment strategies. The current study comprehensively investigated the expression landscape and functional significance of UBE2T, as well as its correlation with cancer cell sensitivity to chemotherapy/radiotherapy. Multiple levels of evidence suggested that aberrant UBE2T played important roles in pan‑cancer. Information was collected from 16 clinical trials on ubiquitin enzymes, and it was found that these molecules had an important role in the ubiquitin‑proteasome system. Further studies are necessary to explore their feasibility and effectiveness as diagnostic and prognostic biomarkers, or as up/down‑stream and therapeutic targets for cancer treatment.
Insights
Aberrant ubiquitination, particularly involving ubiquitin-conjugating enzyme E2 T (UBE2T), is implicated in various cancers. Further research is needed to explore UBE2T
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer pathogenesis involves genetic and epigenetic alterations.
- Aberrant ubiquitination is a key epigenetic disruption in cancer.
- Ubiquitin-conjugating enzyme E2 T (UBE2T) is increasingly recognized for its role.
Purpose of the Study:
- To review the role of UBE2T in pan-cancer pathogenesis.
- To explore UBE2T's association with chemotherapy and radiotherapy sensitivity.
- To examine small-molecule modulators targeting ubiquitination for cancer treatment.
Main Methods:
- Comprehensive investigation of UBE2T expression landscape and functional significance.
- Analysis of UBE2T's correlation with treatment sensitivity.
- Review of clinical trial data on ubiquitin enzymes and the ubiquitin-proteasome system.
Main Results:
- Evidence indicates UBE2T plays significant roles in pan-cancer.
- Aberrant UBE2T is linked to cancer development and progression.
- Ubiquitin enzymes are crucial components of the ubiquitin-proteasome system.
Conclusions:
- UBE2T is a critical factor in pan-cancer.
- Further studies are essential to validate UBE2T as a biomarker or therapeutic target.
- Targeting ubiquitination pathways offers potential cancer treatment strategies.
More Related Videos
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mechanisms of Retrovirus-induced Cancers

